Peter Doshi is an Assistant Professor of Pharmaceutical Health Services Research at the University of Maryland, an Associate Editor at BMJ, and a leading advocate for clinical trial transparency. On 13 June 2013, a paper authored by Peter Doshi, David Healy, and several others appeared in BMJ. The authors noted that they had obtained access to 178,000 ages of previously confidential drug company documents pertaining to clinical trials which had either never been published in the scientific literature, or which had been misreported. They called upon the sponsors of these trials to publish the unpublished studies, and to formally correct or retract the misreported ones. They further stated that if the sponsors failed to do so, the data would be considered “public access data” that others would be allowed to publish.
